4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001209191-21-029041
Options or other derivatives
- Chief Commercial Officer acquired 44,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Tardio Jason · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-25 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +44,000 | 44,000 | D |
Loading xslF345X03/doc4.xml…